Literature DB >> 24196720

Possible FRAX-based intervention thresholds for a cohort of Chinese postmenopausal women.

E Cheung1, C-L Cheung, A W C Kung, K C B Tan.   

Abstract

SUMMARY: A total of 2,266 postmenopausal Chinese women were followed for 4.5 years to determine the incidence of new fractures. The positive predictive value, negative predictive value, sensitivity and specificity of different treatment strategies were compared. Using a fixed optimal threshold calculated from receiver operating characteristics (ROC) curve had the highest sensitivity but lowest specificity.
INTRODUCTION: There is no specific intervention threshold based on FRAX to guide treatment for Asian populations. This prospective study sought to determine the impact of applying different intervention thresholds to a cohort of Chinese postmenopausal women.
METHODS: This study was part of the Hong Kong Osteoporosis Study. A total of 2,266 treatment-naïve postmenopausal women underwent clinical risk factor and BMD assessments. The subjects were followed to assess fractures. We calculated the FRAX probability of major osteoporotic fractures corresponding to women with prior fractures but no other clinical risk factors. Different treatment strategies which include treating women with prior fractures, women with age-specific FRAX probability corresponding to those with prior fractures, women with osteoporosis as well as women with FRAX probability above a fixed cut-off based on optimizing sensitivity and specificity on the ROC curve were compared.
RESULTS: The mean age at baseline was 62.1 ± 8.5 years, and the mean follow-up time was 4.5 ± 2.8 years. One hundred six new major osteoporotic fractures were reported. An optimal (FRAX, with BMD) cut-off point of 9.95 % was identified. All strategies had negative predictive value of >90 %. Using a fixed cut-off had the highest sensitivity (62.3 %) but lowest specificity (73.5 %) and positive predictive value (10.3 %). Using a fixed cut-off would direct treatment from younger women with lower absolute risk to elderly women with higher absolute risk.
CONCLUSION: Targeting only women with prior fractures is unlikely to reduce fracture burden. Other treatment strategies with higher sensitivity need to be considered but they have different shortcomings.

Entities:  

Mesh:

Year:  2013        PMID: 24196720     DOI: 10.1007/s00198-013-2553-9

Source DB:  PubMed          Journal:  Osteoporos Int        ISSN: 0937-941X            Impact factor:   4.507


  33 in total

1.  Diagnostic criteria for primary osteoporosis: year 2000 revision.

Authors:  H Orimo; Y Hayashi; M Fukunaga; T Sone; S Fujiwara; M Shiraki; K Kushida; S Miyamoto; S Soen; J Nishimura; Y Oh-Hashi; T Hosoi; I Gorai; H Tanaka; T Igai; H Kishimoto
Journal:  J Bone Miner Metab       Date:  2001       Impact factor: 2.626

2.  [Osteoporosis - whom to treat? The importance of FRAX® in Switzerland].

Authors:  Kurt Lippuner
Journal:  Ther Umsch       Date:  2012-03

Review 3.  FRAX updates 2012.

Authors:  Eugene McCloskey; John A Kanis
Journal:  Curr Opin Rheumatol       Date:  2012-09       Impact factor: 5.006

Review 4.  FRAX(®) with and without bone mineral density.

Authors:  John A Kanis; Eugene McCloskey; Helena Johansson; Anders Oden; William D Leslie
Journal:  Calcif Tissue Int       Date:  2011-11-06       Impact factor: 4.333

Review 5.  Pitfalls in the external validation of FRAX.

Authors:  J A Kanis; A Oden; H Johansson; E McCloskey
Journal:  Osteoporos Int       Date:  2011-11-26       Impact factor: 4.507

6.  Cost-effective intervention thresholds against osteoporotic fractures based on FRAX® in Switzerland.

Authors:  K Lippuner; H Johansson; F Borgström; J A Kanis; R Rizzoli
Journal:  Osteoporos Int       Date:  2012-01-06       Impact factor: 4.507

7.  Bone mineral density thresholds for pharmacological intervention to prevent fractures.

Authors:  Ethel S Siris; Ya-Ting Chen; Thomas A Abbott; Elizabeth Barrett-Connor; Paul D Miller; Lois E Wehren; Marc L Berger
Journal:  Arch Intern Med       Date:  2004-05-24

8.  Development of prognostic nomograms for individualizing 5-year and 10-year fracture risks.

Authors:  N D Nguyen; S A Frost; J R Center; J A Eisman; T V Nguyen
Journal:  Osteoporos Int       Date:  2008-03-07       Impact factor: 4.507

9.  European guidance for the diagnosis and management of osteoporosis in postmenopausal women.

Authors:  J A Kanis; E V McCloskey; H Johansson; C Cooper; R Rizzoli; J-Y Reginster
Journal:  Osteoporos Int       Date:  2012-10-19       Impact factor: 4.507

10.  Development and application of a Japanese model of the WHO fracture risk assessment tool (FRAX).

Authors:  S Fujiwara; T Nakamura; H Orimo; T Hosoi; I Gorai; A Oden; H Johansson; J A Kanis
Journal:  Osteoporos Int       Date:  2008-02-22       Impact factor: 4.507

View more
  6 in total

1.  Comparison of strategies for setting intervention thresholds for Chinese postmenopausal women using the FRAX model.

Authors:  Shu-Ying Liu; Meng Huang; Rong Chen; Na Ding; Hong Liu; Zhong-Jian Xie; Zhi-Feng Sheng; Bi-Hua Luo; Yang-Na Ou
Journal:  Endocrine       Date:  2019-05-20       Impact factor: 3.633

2.  The added value of trabecular bone score to FRAX® to predict major osteoporotic fractures for clinical use in Chinese older people: the Mr. OS and Ms. OS cohort study in Hong Kong.

Authors:  Y Su; J Leung; D Hans; O Lamy; T Kwok
Journal:  Osteoporos Int       Date:  2016-08-26       Impact factor: 4.507

3.  The Effect of FRAX on the Prediction of Osteoporotic Fractures in Urban Middle-aged and Elderly Healthy Chinese Adults.

Authors:  Jun Wang; Xuejun Wang; Zhen Fang; Nanjia Lu; Liyuan Han
Journal:  Clinics (Sao Paulo)       Date:  2017-05       Impact factor: 2.365

Review 4.  The diversity of Fracture Risk Assessment Tool (FRAX)-based intervention thresholds in Asia.

Authors:  Sarath Lekamwasam
Journal:  Osteoporos Sarcopenia       Date:  2019-12-16

5.  Performance of FRAX in Predicting Fractures in US Postmenopausal Women with Varied Race and Genetic Profiles.

Authors:  Qing Wu; Xiangxue Xiao; Yingke Xu
Journal:  J Clin Med       Date:  2020-01-20       Impact factor: 4.241

6.  Predicting the intervention threshold for initiating osteoporosis treatment among postmenopausal women in China: a cost-effectiveness analysis based on real-world data.

Authors:  L Cui; T He; Y Jiang; M Li; O Wang; R Jiajue; Y Chi; Q Xu; X Xing; W Xia
Journal:  Osteoporos Int       Date:  2019-11-21       Impact factor: 4.507

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.